ACOG

Marketing Veteran Wells Davis Joins Woodlawn Central Development in Key Role

Retrieved on: 
Jeudi, août 3, 2023
Workforce, ACOG, Housing, United Nations, Network, Rejuvenation, Marketing, CSO, Culture, Wells, White Ribbon Campaign, McDonald's, Quality of life, Saatchi & Saatchi, York University, Microsoft, Public policy, Lexus, Macdonald, UNICEF, Black, BMW, United, Economic development, Leo Burnett, Apple, Apostolic Church, Nike, P&G, Coca-Cola, Empowerment

CHICAGO, Aug. 3, 2023 /PRNewswire/ -- Woodlawn Central, an $895 million mixed-use megadevelopment designed to usher in urban regeneration and equitable economic development on Chicago's South Side, hired veteran brand strategist Wells Davis as chief strategy officer. Davis, a former C-suite executive at Leo Burnett, Saatchi & Saatchi and other major marketing agencies in the United States and Canada, brings more than two decades of experience as a visionary leader and initiator to a diverse development team focused on catalyzing investment in Woodlawn and surrounding South Side communities.

Key Points: 
  • CHICAGO, Aug. 3, 2023 /PRNewswire/ -- Woodlawn Central, an $895 million mixed-use megadevelopment designed to usher in urban regeneration and equitable economic development on Chicago's South Side, hired veteran brand strategist Wells Davis as chief strategy officer.
  • Davis' appointment comes at a time when Woodlawn Central's progress to secure financing and efforts to obtain city approval for its planned development designations are accelerating.
  • "Wells shares our deep respect for realizing inclusive community engagement and embracing a visionary approach to achieve transformative economic development," said J. Byron Brazier, Woodlawn Central's lead developer.
  • Davis has had extensive experience as both a chief marketing officer and CSO prior to joining Woodlawn Central.

Leading Maternal Digital Care Platform, eLovu Health, Announces Strategic Partnership with Caduceus Medical Group to Provide End to End Comprehensive Maternal Health

Retrieved on: 
Mercredi, juillet 12, 2023
Blood pressure, Software as a service, Partnership, Pregnancy, ACOG, Telehealth, Depression, DSM-IV codes, Health, Suicide, American College of Obstetricians and Gynecologists, Anxiety, Prenatal care, OBGYN, Intelligence, Doula, Woman, Caduceus, Maternal death, Certified Health Executive, Mother, CDC, Digital health, MD, OB, Patient, CMG, Pre-eclampsia, John DeNicola, Medicine, Entrepreneurship, Digital, American College, Death, Mental health, Nursing, Birth control, Gynaecology

CUPERTINO, Calif., July 12, 2023 /PRNewswire/ -- eLovu Health, the leading B2B digital wellness maternal health data platform, today announced a strategic three year partnership with Caduceus Medical Group, the only physician owned and managed multi-specialty medical group in Orange County, California. eLovu Health provides a SaaS-based digital health platform that integrates with OBGYN clinics across the US to provide key insights and access to first in world care. This partnership comes at a critical time in California where the current and projected OBGYN shortages have been widely reported.

Key Points: 
  • eLovu Health provides a SaaS-based digital health platform that integrates with OBGYN clinics across the US to provide key insights and access to first in world care.
  • Noel Pugh, JD/PhD, Women's Health Executive, Dr. Santosh Pandipati, Maternal-Fetal Medicine Physician, and Kamal Gogineni, Digital Health serial entrepreneur, announce the launch of eLovu Health, a Digital Wellness Maternal Care Data Platform.
  • eLovu's SaaS-based digital wellness platform integrates with clinical practices and brings together leading maternal health technologies and workflows in one end-to-end care solution.
  • Launched publicly earlier this month, eLovu Health is already seeing steady growth while addressing physician burnout and maternal health disparities.

United States Non Invasive Prenatal Testing (NIPT) Market Analysis Report 2023: Size, Market Share, Insights, Growth, Trends, Opportunities, Key Players, Competitive Analysis and Forecasts 2019-2031 - ResearchAndMarkets.com

Retrieved on: 
Vendredi, juillet 7, 2023
Medical Devices, Health, ACOG, Noninvasive prenatal testing, Happening, USD, Incidence, Risk, NIPT, Dietary supplement, Medical imaging, Semiconductor, Medical device, Growth

The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031.

Key Points: 
  • The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031.
  • The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 - 2031.
  • What is the total market size for non-invasive prenatal testing in the United States and what are the projections (through 2031) for this market?
  • Key Players in the United States Non-Invasive Prenatal Testing Market are Listed Below:

NCC Volunteers inducted into the Inaugural Class of AWHONN Fellows

Retrieved on: 
Mercredi, juin 28, 2023
Neonatal nursing, Section, APRN, Hospital, Journal, Patient, OB, HCA, L&D, Fellows, HCA Healthcare, APN, MSN, Teaching, Policy, Prenatal development, Nursing, National Certification Corporation, Research, American College of Nurse-Midwives, MS, Certification, Patient safety, Book, St. Joseph's Hospital, Volunteering, Perioperative, ACOG, Women's health, Nursing credentials and certifications, Public policy, Association of Women's Health, Obstetric and Neonatal Nurses, National Volunteer Fire Council, Publication, Fellow, Northwestern Memorial Hospital, National Board for Certified Counselors, Journal of Perinatal & Neonatal Nursing, NCC, Education, Evidence-based practice, Woman, BSN, DNP, Health, Social and Behavioral Sciences Team, Certificate, AWHONN

CHICAGO, June 28, 2023 /PRNewswire-PRWeb/ -- The Fellow of the Association of Women's Health, Obstetric and Neonatal Nurses (FAWHONN) recognizes nurse leaders who have made substantive and sustained contributions to the health of women and newborns beyond the expectations of their role. They have demonstrated outstanding contributions to clinical practice, research, education, advocacy, or policy at the regional, national, or global level that is reflective of AWHONN's mission and vision. Becoming an AWHONN Fellow demonstrates a commitment to the profession and to the highest standards of nursing care in the specialty of women's health, obstetric, or neonatal nursing.

Key Points: 
  • Ms. Swinton currently serves as the Secretary-Treasurer on the NCC Board of Directors and as a team member on the Obstetric Nursing Content Exam.
  • Ms. Swinton is passionate about clinical competency and professional development, patient safety, and evidence-based practice to enhance or design education initiatives.
  • Her professional and personal values align well with NCC's vision of a healthcare system transformed by professionals who are certified.
  • She has contributed to AWHONN publications, position statements and books, and has been a speaker at many AWHONN state conferences and annual conventions.

Dr. Gary Frishman of Boston IVF Named A 2023 Top Fertility Doctor in Rhode Island

Retrieved on: 
Lundi, juin 5, 2023
Surgical Council on Resident Education, ACOG, Society, Life, American College of Obstetricians and Gynecologists, National Association of Professors of Hebrew, Women's health, System, Top, Reproductive endocrinology and infertility, Clinical professor, IVF, IUI, American Society for Reproductive Medicine, Journal, Brown University, Patient, Physician, Fertility, Council, Big Brothers Big Sisters, ASRM, American College, Reproductive medicine, AAGL, Alpert Medical School, Education, Nursing, Mineral oil, Birth control, Obstetrics, MD, Gynaecology

PROVIDENCE, R.I., June 5, 2023 /PRNewswire-PRWeb/ -- Boston IVF, a worldwide leader of fertility treatment and family building, is pleased to announce that reproductive endocrinologist Gary N. Frishman, MD(he/him) has been selected by Rhode Island Monthly as a 2023 Top Fertility Doctor in Rhode Island.

Key Points: 
  • PROVIDENCE, R.I., June 5, 2023 /PRNewswire-PRWeb/ -- Boston IVF , a worldwide leader of fertility treatment and family building, is pleased to announce that reproductive endocrinologist Gary N. Frishman, MD (he/him) has been selected by Rhode Island Monthly as a 2023 Top Fertility Doctor in Rhode Island.
  • Dr. Frishman has been named a Top Fertility Doctor in every Rhode Island Monthly's Top Doctor article since the award's inception in 1992.
  • Alongside his Rhode Island Monthly recognition, Dr. Frishman has earned national and international acknowledgment for his contributions to Women's Health.
  • Additionally, he has served on the boards of Big Sisters of Rhode Island, Day One Rhode Island, City Year Providence, and Rhode Island Blood Center's Advocacy Board.

Alpha Cognition Launches $6.5 Million Private Placement

Retrieved on: 
Mardi, mai 30, 2023
Nursing, Health, Neurology, Managed Care, Pharmaceutical, Biotechnology, Person, ACOG, CSE, Cognition, Research, News, Security (finance)

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”) announces a private placement offering of up to $6,500,000 of units at a price of $0.22 per unit.

Key Points: 
  • Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”) announces a private placement offering of up to $6,500,000 of units at a price of $0.22 per unit.
  • Each unit will consist of one common share and one-half of a share purchase warrant.
  • The Company expects to use the net proceeds from the offering for research and development, general and administrative matters, and working capital.
  • Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

Retrieved on: 
Jeudi, mai 11, 2023
Science, Obstetrics, American College of Obstetricians and Gynecologists, ACOG, American College, ACSM, Nursing, Management, Birth control, Gynaecology

ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company’s management team will be attending the annual American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting (ACSM) being held May 19-21, 2023 in Baltimore, Maryland.

Key Points: 
  • ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company’s management team will be attending the annual American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting (ACSM) being held May 19-21, 2023 in Baltimore, Maryland.
  • ACSM is a scienfific meeting for the leading experts in obstetrics and gynecology.
  • Members of the Femasys management team will be showcasing its commercially available products FemVue®, FemCath®, and FemCerv® and product candidate FemBloc® at booth #2605.

Babyscripts and MemorialCare Mark Three-year Partnership with Significant Results in Blood Pressure Risk Identification and Patient Engagement in Maternal Populations

Retrieved on: 
Mercredi, mai 10, 2023
Blood pressure, Partnership, Pregnancy, ACOG, Thornburgh v. American College of Obstetricians & Gynecologists, Prenatal care, Maternal health, Mother, CDC, Hypertension, BP, Patient, Risk, Child, Obstetrics, Mortality, System, American College, Health, Medical imaging, Nursing, Medical device, Gynaecology

WASHINGTON, May 10, 2023 /PRNewswire-PRWeb/ -- Babyscripts, the leading virtual care platform for managing obstetrics, marks three years of partnership with MemorialCare, a nonprofit integrated health system in Orange and Los Angeles counties. Since the inception of the partnership, MemorialCare has captured more than 17K blood pressure readings via remote patient monitoring powered by Babyscripts myBloodPressure, with 6% of these triggering an intervention protocol.

Key Points: 
  • Since the inception of the partnership, MemorialCare has captured more than 17K blood pressure readings via remote patient monitoring powered by Babyscripts myBloodPressure, with 6% of these triggering an intervention protocol.
  • Babyscripts and MemorialCare partnered in 2020 to improve outcomes and reduce barriers of access to care for mothers in Southern California through Babyscripts Virtual Maternity Care.
  • In 2021, the partnership expanded beyond the MemorialCare Medical Group patients to offer the Babyscripts' platform to almost all patients that deliver at MemorialCare Hospitals.
  • With remote patient monitoring of blood pressure through Babyscripts myBloodPressure, MemorialCare providers align with industry guidance from the American College of Obstetricians and Gynecologists (ACOG) and others to manage patient risk.

Wellness Brand BabyRx Launches its Highly Effective, Natural Product Line to Support Men and Women through Fertility, Pregnancy, and Postpartum

Retrieved on: 
Jeudi, avril 27, 2023
American Pregnancy Association, Pregnancy, ACOG, Probiotic, American College of Obstetricians and Gynecologists, NSF, Nutrient, Woman, MBA, Research, Science, Mother, CDC, Vitamin, Fertility, Pharmacist, Ecosystem, American College, Health, FDA, Dietary supplement, Gynaecology

NEW YORK, April 27, 2023 /PRNewswire/ -- BabyRx is a groundbreaking wellness company that provides fertility, pregnancy, and postpartum vitamins, created with clinically validated, 100% natural ingredients. Each supplement, including Men's and Women's Fertility, Prenatals, Postnatals, and Probiotics, delivers a comprehensive range of nutrients often lacking in comparable products on the market. BabyRx saw an opportunity to meet couples at every stage of the parenting journey by offering a selection of supplements made in the USA, completely free from artificial ingredients and fillers.

Key Points: 
  • NEW YORK, April 27, 2023 /PRNewswire/ -- BabyRx is a groundbreaking wellness company that provides fertility, pregnancy, and postpartum vitamins, created with clinically validated, 100% natural ingredients.
  • Anastasia Shorr, and her husband Mark Shorr, founded BabyRx shortly after graduating from Wharton's MBA program, while she was newly pregnant.
  • However, I couldn't find a vitamin brand that I trusted for my pregnancy needs," said Anastasia Shorr, BabyRx's Co-founder and CEO.
  • BabyRx's innovative products are formulated with clinically-backed highly absorbent nutrient forms that include clean and natural ingredients made in the USA.

With Demand for Pelvic Health Exploding, Leading Pelvic Floor PT Provider, Origin, Expands Nationwide

Retrieved on: 
Mercredi, avril 19, 2023
Allergen, Pregnancy, ACOG, Obstetrics, Quality of life, Woman, PT, Pelvic floor dysfunction, Pelvic floor, Patient, Standard of care, Menopause, WHO, American College, Health, World Health Organization, Birth control, Nursing, Origin, Gynaecology

LOS ANGELES, April 19, 2023 /PRNewswire/ -- Origin , the leading U.S. provider of women's health and pelvic floor physical therapy, is now available nationwide.

Key Points: 
  • LOS ANGELES, April 19, 2023 /PRNewswire/ -- Origin , the leading U.S. provider of women's health and pelvic floor physical therapy, is now available nationwide.
  • Origin's expert network is now available to the millions of Americans who suffer from pelvic floor dysfunction.
  • And yet there is one pelvic floor PT for every 4,000 people who need help each year and a dearth of virtual options.
  • Many patients also live in pelvic floor PT 'deserts,' leaving them with limited or no options to see a provider in person.